(1)       FTO Genotype and the Weight Loss Benefits of Moderate Intensity Exercise. Mitchell JA, Church TS, Rankinen T, Earnest CP, Sui X, Blair SN. Obesity (Silver Spring). 2010;18(3):641-3.

(2)       ACTN3 Genotype in Professional Endurance Cyclists. Lucia A, Gomez-Gallego F, Santiago C, Bandres F, Earnest CP, Rabadan M, Alonso JM, Hoyos J, Cordova A, Villa G, Foster C. Int J Sports Med. 2006;27(11):880-4.

(3)       PPARGC1A Genotype (Gly482ser) Predicts Exceptional Endurance Capacity in European Men. Lucia A, Gomez-Gallego F, Barroso I, Rabadan M, Bandres F, San Juan AF, Chicharro JL, Ekelund U, Brage S, Earnest CP, Wareham NJ, Franks PW. J Appl Physiol. 2005;99(1):344-8.

(4)       Is There an Association between Ace and CKMM Polymorphisms and Cycling Performance Status During 3-Week Races? Lucia A, Gomez-Gallego F, Chicharro JL, Hoyos J, Celaya K, Cordova A, Villa G, Alonso JM, Barriopedro M, Perez M, Earnest CP. Int J Sports Med. 2005;26(6):442-7.